- Economic Impact
- Nano Network
Augie Sick operates a private consulting practice focused on start-up or early stage biotechnology companies that have a need for experienced operations management and deal expertise; providing advisory and coaching services for founders, executives and leadership teams. He is a co-founder and managing director of Cascade Prodrug, Inc. a development stage company engaged in anti-cancer therapeutics. Mr. Sick currently serves as a director of Active Motif, Inc., Floragenex, Inc., Yecuris Corporation, the Sacred Heart Medical Center Foundation and the External Advisory Committee for the Oregon Clinical and Translational Research Institute (OCTRI). Previously, Mr. Sick was a senior executive for Invitrogen Corporation, a career that started as the 20th employee and covered more than 18 years. In November 2008, Invitrogen and Applied Biosystems merged to form a new entity, Life Technologies, having over 9500 employees and revenues greater than $3.5B. With the change-in-control Mr. Sick retired from Life Technologies in January 2009. In 2006, he was made General Manager of Invitrogen’s $150M annual revenue Cellular Analysis Business where he grew its revenues to about $225 within 2 years. In addition to its primary research supply market, the Cellular Analysis Business provided several hundred Class I IVD products for the diagnosis of cancer and was the first business within Invitrogen to receive a Pre-Market Approval (“PMA”) from the FDA for a Class III IVD. From 2003 to 2006, Mr. Sick was the President of Molecular Probes, Inc. after being acquired for $365M by Invitrogen in August 2003. Previously, he held positions as Vice President Corporate Development and Strategy and Vice President Business Development. During his tenure at Invitrogen, he orchestrated the acquisition of 18 companies and was responsible for over 100 licensing deals. Mr. Sick began his biotechnology career in 1986 as a research associate for Mycogen Corporation, a San Diego startup where he developed many novel molecular biology methods. He is the key inventor on 34 issued US Patents. Mr. Sick received a B.A. in Biochemistry and Cell Biology from the University of California San Diego.
Augie can be reached by phone at 541-521-8834 and by email at email@example.com.